glp 1 drugs novo nordisk launches Wegovy weight-loss pill in US, triggering price war | Pharmaceuticals industry With FDA approval of Wegovy
Description
A 2025 meta-analysis looked at five studies on GLP-1s for people with eating disorders and found that people with BED taking a GLP-1 showed a reduction in binge eating symptoms and lost significantly more weight compared to control groups
We learned this by experience
Peer review Peer review information Nature Medicine thanks Qiwei Li, Carel le Roux and Katherine Tuttle for their contribution to the peer review of this work
Cirincione B, Mager DE
The mice received an intraperitoneal administration of isotonic saline (0.5 ml) to compensate for potential fluid loss
Abstract Background Glucagon-like peptide-1 receptor agonists, originally developed for managing type 2 diabetes, have gained attention for their weight-reducing and broader biological effects
